[6] Similarly, observational studies using healthcare databases have suggested that patients prescribed GLP-1 agonists for diabetes or obesity appear to have lower rates of alcohol-related hospital admissions and reduced self-reported drinking compared to those on other medications, though these findings are limited by potential confounding factors
"Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas"
Federal insurers like TRICARE and Medicaid also cover some obesity treatments, and Medicare is currently working to overcome a regulatory barrier to covering GLP-1s
Semaglutide GLP-1 injections have been shown to reduce the risk of major cardiovascular events, such as heart attack and stroke, in people with type 2 diabetes
The NHS recommends at least 150 minutes of moderate-intensity activity or 75 minutes of vigorous activity weekly, plus strength exercises on two or more days
Brand Claims Notice: Certain marketing claims on the brand's website - including "America's #1 Rated," "Doctor-Approved," and claims about delivering ingredients "to your bloodstream" via transdermal delivery - are the brand's statements
